74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Avantor Inc
Closed
SectorBasic materials
15.43 -0.39
Overview
Share price change
24h
Min
14.96
Max
15.62
Income | 443M 500M |
|---|---|
Sales | -28M 1.7B |
P/E Sector Avg | 14.385 43.137 |
EPS | 0.27 |
Profit margin | 29.669 |
Employees | 13,500 |
EBITDA | 504M 730M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +43.18% upside |
Next Earnings | 25 Apr 2025 |
|---|
Market Cap | 10B |
|---|---|
Previous open | 15.82 |
Previous close | 15.43 |
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Avantor Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Avantor Inc Forecast
Price Target
By TipRanks
43.18% upside
12 Months Forecast
Average 22.15 USD 43.18%
High 26 USD
Low 18 USD
Based on 13 Wall Street analysts offering 12 month price targets forAvantor Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
